Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to core study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:44:30.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The Locations section was reorganized to add a top-level Locations header and individual province/municipality subsections (Anhui, Beijing Municipality, Chongqing Municipality, etc.), replacing the previous per-location headers.
    Difference
    2%
    Check dated 2025-12-23T12:47:15.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added 'Type 2 diabetes' as a study topic tag. Added 'MedlinePlus Genetics' as a related topic.
    Difference
    0.1%
    Check dated 2025-12-16T03:17:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page removes the condition 'Type 2 Diabetes Mellitus' from the study description and related topics, and the related topic 'MedlinePlus Genetics' is removed.
    Difference
    0.1%
    Check dated 2025-12-09T00:40:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Publications section now states publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T16:56:54.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The page removed the banner noting a lapse in government funding and the NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T14:59:38.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.